Premium
Duration of life in the three common variants of primary progressive aphasia: A retrospective study in a tertiary memory clinic
Author(s) -
Tastevin Maud,
Lavoie Monica,
Sablonnière Justine De La,
Laforce Robert
Publication year - 2021
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1002/alz.050674
Subject(s) - primary progressive aphasia , medicine , natural history , pediatrics , disease , retrospective cohort study , dementia , frontotemporal dementia
Background Primary progressive aphasias (PPAs) are a group of neurodegenerative disorders characterized by an insidious and progressive language impairment. Clinical expression and underlying pathology remain highly heterogeneous. To date, there is a lack of knowledge on the natural history of each of the three main variants, particularly mortality. Moreover, advanced stages and end of life issues are rarely discussed with caregivers and families at diagnosis. In turn, this can cause additional psychological distress.We studied the natural history of the three main variants of PPA. More specifically, we focused on mortality and end of life issues in an attempt to better prepare patients and their families. Method We retrospectively studied all deceased patients with a diagnosis of PPA that had been followed at our tertiary memory clinic over the past twenty years ( n =83). Clinical data included age of onset of symptoms, duration of illness, age at death and specific cause of death. Result Age at death was similar across all three PPA variants but there was less variability in the non‐fluent variant (nfvPPA) group (M=76.6, SD=6.2) than in the semantic variant (svPPA; M=74.1, SD=8.5) or the logopenic variant (lvPPA; M=76.1, SD=9.1) groups. Age at onset of symptoms was earlier for svPPA participants (M=64.5, SD=8.3) then for the two other variants (lvPPA: M=69.3, SD= 10.7; nfvPPA: M=70.4, SD=6.3). Consequently, duration of the disease (number of years between symptoms’ onset and death) was longer for svPPA participants (M=9.6, SD=3.0) than for nfvPPA and lvPPA participants (respectively M=6.2, SD=2.1 and M=7.0, SD=2.9). Surprisingly, cause of death was unknown for most of the participants. When available ( n =15), it included sepsis ( n =6), respiratory failure ( n =4), neoplasia ( n =3) and stroke ( n =2), and. There were no differences in causes of death among PPA variants. Conclusion Despite similar age of death across PPA variants, disease duration was longer in the svPPA. Causes of death per se were similar among PPAs. Future studies should include more participants with better emphasis on causes of death. Nonetheless, our study provides useful information about the natural history of the common variants of PPA.